FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116128210> ?p ?o ?g. }

• W2116128210 abstract "To evaluate the efficacy and toxicity of the combination regimen of paclitaxel, cisplatin and 5-FU (PCF) as first-line or second-line therapy in patients with advanced gastric and esophagogastric junction (EGJ) adenocarcinoma in China.The patients were treated with paclitaxel 150 mg/m(2) on d1; fractionated cisplatin 15 mg/m(2) and continuous infusion 5-FU 600 mg/(m(2)·d) intravenously on d1-d5 of a 21-d cycle until disease progression or unacceptable toxicities.Seventy-five patients have been enrolled, among which, 41 received PCF regimen as the first-line therapy (group A) and 34 received the regimen as the second-line therapy (group B) with the median age of 59 years old and Karnofsky performance status (KPS) score ≥80. Toxicities were analyzed in all 75 patients. Seventy-one patients were evaluable for efficacy. The median overall survival (mOS) was 12.0 months (95% CI: 7.9-16.2 months) in group A and 7.3 months (95% CI: 4.3-10.3 months) in group B, respectively. The median progression-free survival (mPFS) was 5.7 months (95% CI: 4.1-7.2 months) and 5.0 months (95% CI: 3.1-6.9 months), respectively. The response rate (CR+PR) was 40% (16/40; 95% CI: 24.9-56.7%) in group A and 22.6% (7/31; 95% CI: 9.6-41.1%) in group B. Major grade 3 or 4 adverse events include neutropenia (41.3%), febrile neutropenia (9.3%), nausea/anorexia (10.7%), and vomiting (5.3%). There was no treatment-related death.The combination chemotherapy with PCF is active and tolerable as first-line and second-line therapy in Chinese patients with advanced gastric and EGJ adenocarcinoma. The response and survival of PCF are same as those of DCF, but the tolerance is much better." @default.
• W2116128210 created "2016-06-24" @default.
• W2116128210 creator A5022200044 @default.
• W2116128210 creator A5030171451 @default.
• W2116128210 creator A5035804461 @default.
• W2116128210 creator A5037989560 @default.
• W2116128210 creator A5038822352 @default.
• W2116128210 creator A5040575560 @default.
• W2116128210 creator A5049678335 @default.
• W2116128210 creator A5059392900 @default.
• W2116128210 creator A5079152412 @default.
• W2116128210 creator A5081853954 @default.
• W2116128210 creator A5088343715 @default.
• W2116128210 creator A5090435133 @default.
• W2116128210 date "2012-12-01" @default.
• W2116128210 modified "2023-10-14" @default.
• W2116128210 title "Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study." @default.
• W2116128210 cites W1940754997 @default.
• W2116128210 cites W1992103975 @default.
• W2116128210 cites W1994843088 @default.
• W2116128210 cites W2008457228 @default.
• W2116128210 cites W2015699114 @default.
• W2116128210 cites W2020830322 @default.
• W2116128210 cites W2022844202 @default.
• W2116128210 cites W2027321342 @default.
• W2116128210 cites W2039150221 @default.
• W2116128210 cites W2054247854 @default.
• W2116128210 cites W2055420184 @default.
• W2116128210 cites W2068225833 @default.
• W2116128210 cites W2069434099 @default.
• W2116128210 cites W2090541852 @default.
• W2116128210 cites W2095677070 @default.
• W2116128210 cites W2106787323 @default.
• W2116128210 cites W2116214127 @default.
• W2116128210 cites W2122866527 @default.
• W2116128210 cites W2126532720 @default.
• W2116128210 cites W2130522735 @default.
• W2116128210 cites W2131597845 @default.
• W2116128210 cites W2142076329 @default.
• W2116128210 cites W2146473440 @default.
• W2116128210 cites W2148589524 @default.
• W2116128210 cites W2170346929 @default.
• W2116128210 cites W2415936575 @default.
• W2116128210 doi "https://doi.org/10.3978/j.issn.1000-9604.2012.08.04" @default.
• W2116128210 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3551331" @default.
• W2116128210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23359329" @default.
• W2116128210 hasPublicationYear "2012" @default.
• W2116128210 type Work @default.
• W2116128210 sameAs 2116128210 @default.
• W2116128210 citedByCount "9" @default.
• W2116128210 countsByYear W21161282102013 @default.
• W2116128210 countsByYear W21161282102014 @default.
• W2116128210 countsByYear W21161282102015 @default.
• W2116128210 countsByYear W21161282102016 @default.
• W2116128210 countsByYear W21161282102017 @default.
• W2116128210 countsByYear W21161282102019 @default.
• W2116128210 countsByYear W21161282102020 @default.
• W2116128210 crossrefType "journal-article" @default.
• W2116128210 hasAuthorship W2116128210A5022200044 @default.
• W2116128210 hasAuthorship W2116128210A5030171451 @default.
• W2116128210 hasAuthorship W2116128210A5035804461 @default.
• W2116128210 hasAuthorship W2116128210A5037989560 @default.
• W2116128210 hasAuthorship W2116128210A5038822352 @default.
• W2116128210 hasAuthorship W2116128210A5040575560 @default.
• W2116128210 hasAuthorship W2116128210A5049678335 @default.
• W2116128210 hasAuthorship W2116128210A5059392900 @default.
• W2116128210 hasAuthorship W2116128210A5079152412 @default.
• W2116128210 hasAuthorship W2116128210A5081853954 @default.
• W2116128210 hasAuthorship W2116128210A5088343715 @default.
• W2116128210 hasAuthorship W2116128210A5090435133 @default.
• W2116128210 hasConcept C121608353 @default.
• W2116128210 hasConcept C126322002 @default.
• W2116128210 hasConcept C143998085 @default.
• W2116128210 hasConcept C2776694085 @default.
• W2116128210 hasConcept C2777292972 @default.
• W2116128210 hasConcept C2778239845 @default.
• W2116128210 hasConcept C2780456651 @default.
• W2116128210 hasConcept C2781182431 @default.
• W2116128210 hasConcept C2781413609 @default.
• W2116128210 hasConcept C29730261 @default.
• W2116128210 hasConcept C2993283237 @default.
• W2116128210 hasConcept C3019338163 @default.
• W2116128210 hasConcept C3019864225 @default.
• W2116128210 hasConcept C71924100 @default.
• W2116128210 hasConceptScore W2116128210C121608353 @default.
• W2116128210 hasConceptScore W2116128210C126322002 @default.
• W2116128210 hasConceptScore W2116128210C143998085 @default.
• W2116128210 hasConceptScore W2116128210C2776694085 @default.
• W2116128210 hasConceptScore W2116128210C2777292972 @default.
• W2116128210 hasConceptScore W2116128210C2778239845 @default.
• W2116128210 hasConceptScore W2116128210C2780456651 @default.
• W2116128210 hasConceptScore W2116128210C2781182431 @default.
• W2116128210 hasConceptScore W2116128210C2781413609 @default.
• W2116128210 hasConceptScore W2116128210C29730261 @default.
• W2116128210 hasConceptScore W2116128210C2993283237 @default.
• W2116128210 hasConceptScore W2116128210C3019338163 @default.
• W2116128210 hasConceptScore W2116128210C3019864225 @default.
• W2116128210 hasConceptScore W2116128210C71924100 @default.
• W2116128210 hasLocation W21161282101 @default.
• W2116128210 hasOpenAccess W2116128210 @default.

• next